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Purpose:  to investigate  the  added  value  of  qualitative  and  quantitative  evaluation  of diffusion  weighted
(DW)  magnetic  resonance  (MR)  imaging  in response  assessment  after  neoadjuvant  chemo-radiotherapy
(CRT)  in  patients  with  locally  advanced  rectal  cancer  (LARC).
Methods:  31  patients  with  LARC  (stage  ≥ T3)  were  enrolled  in  the  study.  All  patients  underwent  conven-
tional  MRI  and  DWI  before  starting  therapy  and  after  neoadjuvant  CRT.  All  patients  underwent  surgery;
pathologic  staging  represented  the  reference  standard.  For  qualitative  analysis,  two  radiologists  retro-
spectively  reviewed  conventional  MR  images  and  the  combined  set of  conventional  and  DW  MR  images
and  recorded  their  conﬁdence  level  with  respect  to  complete  response  (ypCR).  For quantitative  analysis,
tumor’s  apparent  diffusion  coefﬁcient  (ADC)  values  were  measured  at each  examination.  ADC  pre-CRT,
ADC  post-CRT  and    ADC  post−ADC  pre  of the three  groups  of  response  (ypCR,  partial  response  ypPR,  sta-
ble disease  ypSD)  were  compared.  Receiver-operating  characteristics  (ROC)  curve  analysis  was  employed
to  investigate  the  discriminatory  capability  for ypCR,  responders  (ypCR,  ypPR)  and  ypSD  of  each  measure.
Results:  addition  of DWI  to conventional  T2-weighted  sequences  improved  diagnostic  performance  of
MRI  in  the  evaluation  of ypCR.  A low  tumor  ADC  value  in the  pre-CRT  examination,  a high  ADC value  in
the  post-CRT  examination,  a high    ADC  post−ADC  pre [>0.3  (×10−3 mm2/s)]  were  predictive  of  ypCR.
Conclusions:  DW  sequences  improve  MR  capability  to  evaluate  tumor  response  to  CRT.  Nevertheless,  no
functional  MR  technique  alone  seems  accurate  enough  to  safely  select  patients  with  ypCR.
© 2016  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND. Introduction
Rectal cancer is one of the most frequent neoplasias, with an
ncidence of 40 in 100,000 [1]. Over the last two decades its treat-
ent has undergone many changes and innovation, thus more
recise preoperative evaluation leaded to reﬁned patient selection
or appropriate treatment strategies. The tumor stage determines
hether radiation and chemotherapy should be used in addition
o surgery. In particular, T1-T2 N0 tumors are managed surgically,
∗ Corresponding author at: Radiodiagnostic and Radiotherapy Unit – University
ospital “Policlinico-Vittorio Emanuele”, Via Santa Soﬁa 78, 95123 Catania, Italy.
E-mail address: pietrofoti@hotmail.com (P.V. Foti).
ttp://dx.doi.org/10.1016/j.ejro.2016.06.003
352-0477/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article 
/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
without neoadjuvant treatment whereas neoadjuvant chemo-
radiotherapy (CRT) followed by total mesorectal excision (TME)
surgery represents the standard treatment for locally advanced
rectal carcinoma (≥T3; any T, N+) [2].
According to literature data 15–27% of the patients treated with
CRT achieve a pathological complete response (ypCR), a partial
response is seen in 54–75% and others show no response at all [3].
In view of these advances of CRT, alternative approaches to rad-
ical surgery have been proposed. Therefore, staging rectal cancer
before and after CRT and assessing tumor response have become a
very critical issue and imaging studies play a key role with relevant
implications in patients’ management.
On one hand response assessment during CRT could possi-
bly re-orientate non-responding patients to a different treatment
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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odality (e.g. early surgery) or to treatment intensiﬁcation (e.g.
ose escalation or addition of targeted agents); on the other hand
esponse assessment before surgery may  enable physicians to offer
atients who achieve a clinical complete response less extensive
urgery, such as sphincter-saving local excision [4], or even a ‘wait-
nd-see’ policy [5,6].
According to the European guidelines, magnetic resonance (MR)
maging is the most accurate technique for predicting tumor
tage [5,7]. Nevertheless, MRI, as a morphologic imaging modal-
ty, has inherent limitations in the differentiation of residual viable
umor from diffuse ﬁbrotic change; therefore, conventional MRI
equences cannot be used to predict complete response to CRT [8,9].
The reported overall accuracy of MRI  in predicting the patho-
ogic stage of nonirradiated rectal cancer is 71–91% (mean 85%) for
 staging and 43–85% (75%) for N staging; on the other hand the
eported overall accuracy of MRI  in predicting the pathologic stage
f irradiated rectal cancer is 47–54% (50%) for T staging and 64–68%
65%) for N staging [7,10].
Since conventional MR  sequences are insufﬁcient for reliably
ssessing these critical issues there is considerable enthusiasm
or employing functional imaging techniques such as diffusion-
eighted (DW) MR  imaging [11], which may  depict microstructural
nd metabolic treatment-induced changes of the tumor before
orphological changes become apparent. DWI  allows to perform
uantitative measures such as apparent diffusion coefﬁcient (ADC);
t may  be used as a noninvasive imaging biomarker of tumor aggres-
iveness [12,13] and to monitor and predict tumor response to CRT
14].
In recent years different imaging tools either volumetric (tumor
olume reduction rate [15], magnetic resonance volumetry [16]) or
unctional [6] have been investigated as potential imaging-based
iomarker of treatment response; in particular, the role of qualita-
ive and quantitative DWI  ﬁndings for prediction of tumor response
o CRT has been evaluated.
Kim et al. [8] demonstrated that in patients with locally
dvanced rectal cancer, adding DW MR  imaging to conventional
R imaging yields better diagnostic accuracy than use of conven-
ional MR  imaging alone in the evaluation of complete response to
eoadjuvant CRT.
Other studies [6] have investigated the role of ADC measure-
ents (potential markers of response being pre-CRT, post-CRT ADC
easures and ADC) for prediction of treatment outcome and for
arly detection of tumor response in patients with locally advanced
ectal cancer. Sometimes, however the obtained results are discor-
ant and DWI  seems not accurate enough to safely select patients
or organ preservation.
The aims of our study were:
 to investigate the added value of qualitative DW MRI  evaluation
in the response assessment after neoadjuvant CRT in patients
with locally advanced rectal cancer;
 to evaluate the diagnostic performance of rectal cancer’s ADC
measurements, the quantitative parameter of diffusion, for the
assessment of therapeutic response to CRT.
. Materials and methods
.1. Patients
This was a single institution retrospective cohort study. The
ork described has been carried out in accordance with The Code
f Ethics of the World Medical Association (Declaration of Helsinki)
or experiments involving humans and in accordance with recom-
endations of the local ethic committee. Informed consent was
aived due to the retrospective study design.diology Open 3 (2016) 145–152
Between October 2011 and May  2015, 47 patients with diagnosis
of rectal cancer were considered for eligibility.
Inclusion criteria were as follows: histologically proven rectal
carcinoma, staged on rectal MRI  with DWI  T3-4 and/or with positive
regional lymph-node, neoadjuvant CRT, post-CRT rectal MRI with
DWI, subsequent surgery.
Exclusion criteria were: previous CRT for primary rectal car-
cinoma or tumor in other organ (n = 1); contraindication to MR
imaging examination (n = 2); delayed (more than 8 months after
CRT), cancelled surgery or surgery performed in other institution
(n = 2); insufﬁcient quality of MR  examination (e.g. owing to metal
implants or movement artifacts) (n = 2); distant metastases (n = 4);
lack of follow-up MR  examination (n = 5).
All patients underwent a staging protocol before preoperative
CRT, that included: digital rectal examination, complete blood tests,
colonoscopy, contrast enhanced computed tomography (CT) of the
chest and the abdomen, external pelvic phased-array MR  examina-
tion and transrectal ultrasound.
2.2. Reference standard
Pretreatment stage (cT cN) was compared with pathologic stage
(ypT ypN). Pathologic staging represented the reference standard
and was  based on the TNM staging system (VII ed.).
The response was  graded as follows. No response to treatment
was deﬁned as stable disease (ypSD). A partial response (ypPR) to
treatment was  deﬁned as downstaging, or reduction of at least
one level in T or N staging between the baseline MR exam and
histopathological staging. Pathological complete response (ypCR)
was deﬁned as the absence of any residual tumor cells detected in
the operative specimen (ypT0 ypN0).
2.3. Neoadjuvant CRT treatment plan
CRT was  performed by means of integration between an initial
induction chemotherapy (ICT) and a subsequent concurrent radio-
chemotherapy (CRCT), over a period of 9 weeks.
During the ICT phase, all patients received a FOLFOX 4
chemotherapy schedule for two cycles, with Oxaliplatin 85 mg/m2
in 3 h i.v. infusion (on day 1), 5-Fluoruracil 400 mg/m2 i.v. bolus,
Folinic acid 200 mg/m2, 5-Fluoruracil 600 mg/m2 continuous intra-
venous infusion over 22 h (on day 1 and 2). The cycle was repeated
after 14 days, by previous clinical and haematological examination.
A CT radiotherapy simulation was  conducted during the ICT
phase, in order to prepare the treatment plan.
The CRCT phase requires a continuous i.v. infusion of 5-
Fluoruracil at 250 mg/m2 daily during all radiotherapy treatment
period. Radiation therapy was  conducted with patient in prone
position, by means of a belly board position system, in order to
reduce the dose to the small bowel.
Radiotherapy was  planned using a 3D-Conformal technique
(Fig. 1), to ensure a coverage of the whole pelvis, including rec-
tum, mesorectum, common iliac, internal and external iliac lymph
nodes, obturator lymph nodes. This volume was deﬁned as CTV 1
(Clinical Target Volume 1) and was irradiated to a dose of 45 Gy,
with a conventional fractionation of 1,8 Gy/day. A second volume,
called CTV2, was also deﬁned to give a boost to the site of the pri-
mary tumor in the rectum, by means of a concomitant irradiation
during the last six fractions, after an interval of 6 h from the ﬁrst
fraction. This volume received a dose of 9 Gy, with a fractionation
of 1,5 Gy/day.Using the above described concomitant-boost technique, a total
dose of 54 Gy is given to the primary tumor. This dose is at least
10% higher than that conventionally used in the currently accepted
protocols for neoadjuvant irradiation of rectal cancer.
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Fig. 1. Radiotherapy plan. Radiotherapy dose distribution in axial, coronal and sagittal views. Planning was made through a 3D-conformal technique.
Table 1
MRI  protocol. Synoptic table summarizes the imaging parameters of MR  sequences. Axial T2-weighted SSFSE sequence is used as second localiser. Sagittal T2-weighted
FRFSE  sequence is oriented parallel to the longitudinal axis of the rectum identiﬁed on the previous axial T2-weighted SSFSE sequence. Oblique coronal and oblique axial
T2-weighted FRFSE sequences are oriented respectively perpendicular or parallel to the longitudinal axis of the rectal tumor.
MRI  protocol Axial T2 W
SSFSE
Sagittal T2 W
FRFSE
Oblique coronal
T2 W FRFSE
Oblique axial
T2 W FRFSE
Axial DWI  SE
EPI
Repetition time/Echo time (m s) 765/59 3560/100 3440/100 3440/100 5425/74.8
Flip  angle 90◦ 90◦ 90◦ 90◦ 90◦
Echo train length – 21 23 23 –
Section thickness (mm) 6  3 3 3 5
Interslice gap (mm)  0.6 0,3 0.3 0.3 1
Bandwidht (kHz) 31.25 25 31.25 31.25 250
Field  of view (cm) 38 30 28 28 40
Matrix  320 × 288 288 × 224 288 × 224 288 × 224 160 × 160
No.  of averages 0.54 3 4 4 8
No.  of images 30 30 30 30 24
Frequency direction Right to left Anterior to posterior Right to left Anterior to posterior Right to left
Acquisition time 24 s 4 min  10 s 4 min  41 s 4 min  49 s 2 min  59 s
T pin-ec
2
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w
n
ab-value  (sec/mm2) – – 
2W = T2-weighted, SSFSE = single-shot fast spin-echo, FRFSE = fast relaxation fast s
.4. Imaging technique
All patients were examined by MRI  at two time points: about 1
eek prior to CRT (pre-CRT MRI) and 7 weeks after the end of CRT
post-CRT MRI).
All pre-CRT and post-CRT MRI  examinations were performed
ith a closed-conﬁguration superconducting 1.5-T system (Signa
DxT; GE Healthcare, Milwaukee, Wis) with 57.2 mT/m gradi-
nt strength and 120 T/m/s slew rate, by using an eight-channel
igh-resolution torso coil with array spatial sensitivity technique
ASSET) parallel acquisition. Informed consent of MRI examination
as obtained from all patients at the time of scanning after the
ature and contraindications of the procedure were fully explained.About three hours before the MR  study, the patients performed
 rectal cleansing with a water enema.
Table 1 summarizes our MR  imaging protocol.– – 0−800
ho, DWI  = diffusion-weighted imaging, SE = spin-echo, EPI = echoplanar imaging.
2.5. Image analysis
The evaluation of MR  examinations was performed by two radi-
ologists (a senior radiologist with 7 years of clinical experience in
body MRI  and a junior radiologist with 1 year of practice experi-
ence) who  were blinded to information obtained at surgery and
pathologic analysis.
Qualitative analysis was  performed by the two radiologists in
consensus. They reviewed the two image sets (the conventional
MR image set and the combined set of conventional and DW MR
images) in two  different reading sessions over an 8-week period. To
avoid any recall bias, the order of cases was changed in the second
reading session.First, the radiologists reviewed both the pre-CRT and post-CRT
conventional MR images and recorded their conﬁdence level with
respect to the ypCR during the ﬁrst reading session. CR was deﬁned
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Fig. 2. Complete response. MR  images of a 70-year old man classiﬁed as complete responder on combined set of conventional and DW images and as partial responder
on  T2-weighted images. (a) Pre-CRT axial T2-weighted image shows neoplastic tissue in the middle rectum (white arrow) with nodal involvement (white arrowhead); the
tumor  has spread through the rectal wall into the perirectal fat for less than 5 mm (T3a N2 stage). (b) Pre-CRT DW (b = 800 s/mm2) image shows a focal high signal intensity
area  in the corresponding tumor (white arrow). (c) Pre-CRT ADC map  at the same level shows reciprocal low signal intensity area due to the pathological tissue (white
arrow). The mean ADC value was 0.752 × 10−3 s/mm2. (d) Post-CRT axial T2-weighted image shows a wall thickening of the rectum with low signal intensity (white arrow),
not  clearly depicted as ﬁbrosis. (e) Post-CRT DW (b = 800 s/mm2) image shows no residual high signal intensity in the primary tumor bed. (f) Post-CRT ADC map at the same
level:  the mean ADC value was  1.076 × 10−3 s/mm2. On the basis of qualitative and quantitative DWI  analysis the patient should be considered as complete responder. (g)
Photomicrograph (H&E x800). Complete response (TRG: 4), absence of tumor remnants; ﬁbrous reaction induced by the treatment and calciﬁcations are evident.
Fig. 3. Partial response. MR  images of a 55-year old woman classiﬁed as partial responder both on combined set of conventional and DW images and on T2-weighted images.
(a)  Pre-CRT axial T2-weighted image shows wall thickening of the middle rectum (white arrow) with spread into the perirectal fat for less than 10 mm;  there are also some
lymph  nodes (white arrowhead) into the mesorectal fat (T3b N2). (b) Pre-CRT DW (b = 800 s/mm2) image shows high signal intensity area in the corresponding tumor (white
arrow). (c) Pre-CRT ADC map at the same level shows low signal intensity area due to the pathological tissue (white arrow). The mean ADC value was  0.804 × 10−3 s/mm2.
(d)  Post-CRT axial T2-weighted image shows tumor shrinkage and intermediate signal intensity tissue in the rectal wall, not clearly depicted as ﬁbrosis. (e) Post-CRT DW
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ame  level shows a focal low signal intensity area corresponding to the residual tu
H&E  x800). Intermediate regression (TRG: 2 + 3), predominance of the ﬁbrous reac
s an unidentiﬁed mass or wall thickening in the post-CRT MR
xamination. A partial response (PR) to treatment was deﬁned as
ownstaging, or reduction of at least one level in T or N staging
etween the baseline pre-CRT MR  exam and the post-CRT MR exam.
o response to treatment (stable disease SD) was deﬁned as stable
isease between the two time points MR  examinations.
At the second reading session, the reviewers recorded their con-
dence level with respect to the ypCR for the combined image set
the conventional MR  image set, the pre- and post-CRT DW MR
mage set and the ADC map). CR was deﬁned as nondepiction of
igh signal intensity in the corresponding tumor on DW MR  images.
he presence of residual high signal intensity on DW MR  images
low signal intensity on the ADC map) in the corresponding tumor
as considered a sign of a PR. SD was deﬁned as stable disease
etween the two time points MR  examinations. When the ﬁndingsmited to a focal spot in the rectal wall (white arrow). (f) Post-CRT ADC map  at the
white arrow). The mean ADC value was 1.237 × 10−3 s/mm2. (g) Photomicrograph
duced by the treatment and few tumor remnants.
on DW MR images differed from those on conventional MR images,
reviewers gave priority to the ﬁndings of the former ones.
In the quantitative assessment the measurements of the ADC
were performed on both pre-CRT and post-CRT DW MR images by
the two  radiologists in consensus in a successive session, by using
a workstation with diffusion analysis software (Advantage Win-
dows version 4.6, General Electric Medical Systems, Milwaukee,
WI,  USA). To obtain the ADC measurements the radiologists placed
at least three oval regions of interest (ROIs) (mean size 10 mm2;
range 8–14 mm2) on the DW images (b = 0, b = 800 s/mm2) on the
rectal wall in the area of brightest signal of the clearly visible tumor,
resulting in a total of at least 3 subreadings for each lesion. The
ROIs were delineated excluding cancer margins, distortion artifacts
and macroscopically visible necrotic or cystic portions, and were
automatically copied to the corresponding ADC map. T2-weighted
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Fig. 4. Stable disease. MR  images of a 77-year old man  classiﬁed as stable disease both on combined set of conventional and DW images and on T2-weighted images. (a)
Pre-CRT  axial T2-weighted image shows neoplastic tissue in the middle rectum (white arrow) with nodal involvement (white arrowhead). The tumor has spread into the
mesorectal fat for more than 10 mm (T3c N1 stage). (b) Pre-CRT DW (b = 800 s/mm2) image shows high signal intensity area due to neoplastic tissue (white arrows). (c)
Pre-CRT ADC map  at the same level shows low signal intensity area (white arrow). The mean ADC value was 0.937 × 10−3 s/mm2. (d) Post-CRT axial T2-weighted image
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H&E  x600). Poor regression (TRG: 0 + 1), predominance of areas with tumor remna
mages were observed to assist in correctly identifying the tumor.
ollowing completion of therapy, if there was  no residual tumor
etectable on post-CRT images, the ROIs were traced on what was
onsidered to be the normal residual rectal wall, as much as possible
n the same area used in pre-CRT MR  examination. Subsequently,
he values of all subreadings of each time point examination were
veraged and the mean ADC value was calculated for each lesion.
.6. Statistical analysis
All data are presented as the mean ± standard deviation. The
ata were ﬁrst tested for normality (Shapiro–Wilk’s test) and
omoscedasticity (Levene’s test) and then compared by using one-
r two-way analyses of variance (ANOVAs) followed by post hoc
ultiple comparisons by using Duncan’s test. In particular, the
wo-way ANOVA was performed by applying the mixed model for
ndependent variables (ypCR, ypPR and ypSD groups) and repeated
easures (ADC pre-CRT and ADC post-CRT examination). The one-
ay ANOVA was performed on difference between ADC post and
DC pre ( ADC post−ADC pre) of the three groups (ypCR, ypPR,
pSD).
Analyses were performed by using Statistica 7.0 for Windows
nd the signiﬁcance level was established at p ≤ 0.05.
Diagnostic capabilities of the two image sets (the conventional
R image set and the combined set of conventional and DW MR
mages) for the diagnosis of CR compared with the reference stan-
ard were assessed by measuring accuracy, sensitivity, speciﬁcity,
ositive predictive value (PPV) and negative predictive value (NPV).
able 2
tatistical analysis. Diagnostic capabilities of the two  image sets (the conventional
R  image set and the combined set of conventional and DW MR images) for the
iagnosis of complete response compared with the reference standard.
T2 T2 + DWI
Accuracy% 87.9 97
Sensitivity% 20 (15.1–55.1)a 80 (44.9–151.1)a
Speciﬁcity% 100 100
PPV% 100 100
NPV% 87.5 96.6
PV: positive predictive value; NPV: negative predictive value; DWI: diffusion
eighted imaging.
a Conﬁdence interval limits.the mesorectal fat (T3 stage). (e) Post-CRT DW (b = 800 s/mm2) image shows high
the same level shows low signal intensity area (white arrow). (g) Photomicrograph
rrounded by a poor ﬁbrous reaction induced by the treatment.
Cases in which disease was  understaged were considered as false
negative, cases in which disease was  overstaged were considered
as false positive.
Receiver-operating characteristics (ROC) analysis with the area
under the curve (AUC) was employed to investigate the discrim-
inatory capability for ypCR, responders (ypCR, ypPR) and ypSD of
each repeated measure (ADC pre-CRT, ADC  post-CRT and  ADC
post−ADC pre). For calculation of the sensitivity and speciﬁcity the
optimal threshold was determined by giving equal weighting to
sensitivity and speciﬁcity on the ROC curve [17]. Therefore, for each
repeated measure we calculated AUC for the following independent
variables:
– ypCR versus ypPR and ypSD,
– responders (ypCR, ypPR) versus ypSD,
– ypSD versus responders (ypCR, ypPR).
We used 95% conﬁdence intervals to express the statistical pre-
cision of the results. The above mentioned analysis was  performed
by using MedCalc software for Windows (MedCalc Software version
9.6.4.0, Mariakerke, Belgium).
3. Results
3.1. Patient demographics
31 patients met  the above mentioned study criteria and were
enrolled in the study (21 men  and 10 women, mean age of 65 years
with a range of 41–84 years).
The average interval between pre-CRT MR imaging for tumor
staging and the start of the treatment was 8 days (range, 4–11 days).
The average interval between the completion of CRT and post-
CRT MR  imaging for response evaluation was 51 days (range,
43–57 days). The average interval between post-CRT MR imaging
and surgery was  9 days (range, 5–27 days).
Tumor location was  as follows: anal canal, within 4.0 cm of
the anal verge (n = 7); distal rectum, within 4.1–8.0 cm of the anal
verge (n = 15); middle rectum, within 8.1–12.0 cm of the anal verge
(n = 5); proximal rectum, within 12.1–16.0 cm of the anal verge
(n = 4).
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Table  3
Overall ADC value of rectal cancer and mean ADC value of ypCR, ypPR and ypSD groups at each time point (means ± standard deviation).
Group ADC pre-CRT
(×10−3 mm2/s)
ADC post-CRT
(×10−3 mm2/s)
 ADC post−ADC
pre (×10−3 mm2/s)
overall ADC 0.85 ± 0.09 1.13 ± 0.18 0.28 ± 0.21
ypCR  0.78 ± 0.05 1.28 ± 0.21 0.51 ± 0.18
ypPR  0.84 ± 0.07 1.16 ± 0.16 0.31 ± 0.19
ypSD  0.91 ± 0.12 1.01 ± 0.14 0.11 ± 0.09
ypCR: complete response; ypPR: partial response; ypSD: stable disease; CRT: chemo-radiotherapy.
Table 4
Statistical analysis. ROC curve analysis.
ypCR vs ypPR and
ypSD
responders (ypCR,
ypPR) vs ypSD
ypSD vs responders
(ypCR, ypPR)
ADC pre-CRT OCV ADC (×10−3 mm2/s) 0.8 0.9 0.9
AUC 0.793 0.718 0.718
Sensitivity% 100 81.82 60
Speciﬁcity% 66.67 60 81.82
ADC  post-CRT OCV ADC (×10−3 mm2/s) 1.3 1.1 1.1
AUC 0.763 0.77 0.77
Sensitivity% 60 77.27 70
Speciﬁcity% 92.59 70 77.27
  ADC post−ADC pre OCV ADC (×10−3 mm2/s) 0.3 0.2 0.2
AUC 0.87 0.873 0.873
Sensitivity% 100 72.73 100
.37 
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pCR: complete response; ypPR: partial response; ypSD: stable disease; CRT: chem
All patients underwent surgical excision: low/ultralow anterior
esection (n = 26) and abdominoperineal resection (n = 5); 18/31
atients underwent also temporary diverting loop ileostomy.
At pathological evaluation tumor response was as follows:
 complete response (ypCR) 5/31 patients (16.1%) (Fig. 2);
 partial response (ypPR) 16/31 patients (51.6%) (Fig. 3);
 stable disease (ypSD) 10/31 patients (32.3%) (Fig. 4).
.2. Qualitative analysis
In the evaluation of CR, the diagnostic performance of the second
eading session (combined set of conventional and DW MR  images)
as better than that of the ﬁrst one (conventional MR  image set)
Table 2). Additional DW MR  image interpretation allowed to cor-
ect diagnostic errors made on the basis of conventional MR  image
nterpretation alone (n = 3).
.3. Quantitative analysis
Table 3 shows the overall ADC value of rectal cancer and the
ean ADC value of ypCR, ypPR and ypSD groups at each time point.
The overall ADC value of rectal cancer in the pre-CRT examina-
ion was signiﬁcantly lower than that in the post-CRT examination,
s revealed by the examination effect of the two-way ANOVA (F1,
8 = 88.63; p < 0.00001) (ADC pre-CRT: 0.85 ± 0.09 × 10−3 mm2/s;
DC post-CRT: 1.13 ± 0.18 × 10−3 mm2/s).
In the ypCR and ypPR groups, the ADC value of rectal cancer
n the pre-CRT examination was signiﬁcantly lower than that in
he post-CRT examination, whereas in the ypSD group the dif-
erence was not statistically signiﬁcant, as revealed by post hoc
omparisons on interaction of the two-way ANOVA (F2, 28 = 10.77;
 = 0.0003) (post hoc comparisons: ypCR group, p = 0.00002; ypPR
roup, p = 0.00006; ypSD group, p = 0.07).Moreover, as revealed by post hoc comparisons on interation
f the two-way ANOVA (F2, 28 = 10.77; p = 0.0003), in the pre-CRT
xamination the ADC value of rectal cancer of ypCR group was
igniﬁcantly lower than that of ypSD group (p = 0.04); whereas no100 72.73
otherapy; OCV ADC: optimal cut-off ADC value; AUC: area under the ROC curve.
statistically signiﬁcant difference was  found between ADC value of
rectal cancer of ypCR and ypPR groups (p = 0.2) and between ypPR
and ypSD groups (p = 0.3). In the post-CRT examination the ADC
values of rectal cancer were signiﬁcantly different among the three
groups of tumor response (ypCR vs. ypPR: p = 0.03; ypCR vs. ypSD:
p = 0.0001; ypPR vs. ypSD: p = 0.01).
The  ADC post−ADC pre were signiﬁcantly different among the
three groups of tumor response, as revealed by post hoc compar-
isons of the one-way ANOVA (F2, 28 = 10.77; p = 0.0003) (post hoc
comparisons: ypCR vs. ypPR: p = 0.02; ypCR vs. ypSD: p = 0.0001;
ypPR vs. ypSD: p = 0.02).
The results of ROC curve analysis are shown in Table 4. The 
ADC post−ADC pre showed the best diagnostic capability in iden-
tifying both ypCR and responders (ypCR, ypPR). In particular, when
an ADC > 0.3 (×10−3 mm2/s) was  used as the cut-off value for dis-
tinguishing between the ypCR and ypPR-ypSD groups [area under
the ROC curve (AUC), 0.87], a sensitivity of 100% and a speciﬁcity
of 70.37% were obtained. When an ADC > 0.2 (×10−3 mm2/s) was
used as the cut-off value for distinguishing between the respon-
ders (ypCR, ypPR) and ypSD groups [area under the ROC curve
(AUC), 0.873], a sensitivity of 72.73% and a speciﬁcity of 100% were
obtained.
4. Discussion
In this study we evaluated the diagnostic value of qualitative and
quantitative DWI  ﬁndings in the assessment of tumor response to
neoadjuvant CRT in patients with locally advanced rectal cancer.
Our study demonstrated that:
– the addition of DWI  sequence’s qualitative assessment to con-
ventional high-resolution T2-weighted sequences improves the
diagnostic performance of MRI  in the evaluation of ypCR (sensi-
tivity 80%, speciﬁcity 100%);– in the ypCR group the ADC value of rectal cancer in the per-CRT
examination was  signiﬁcantly lower than that in the post-CRT
examination; in the pre-CRT examination the ADC value of ypCR
group was  signiﬁcantly lower than that of ypSD group;
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  ADC post−ADC pre (sensitivity 100%, speciﬁcity 70.37%) yields
better diagnostic capability than ADC pre-CRT (sensitivity 100%,
speciﬁcity 66.67%) and ADC post-CRT (sensitivity 60%, speciﬁcity
92.59%) in the evaluation of ypCR.
In our case series tumor response rate after CRT was 67.7%, in
articular 16.1% of patients showed a complete tumor response and
1.6% a partial response. These data are substantially in line with
hose ones from scientiﬁc literature in which complete response
ate ranges from 15% to 27% and partial response rate from 54% to
5% [3].
The ﬁrst of our purposes was to investigate the added value of
ualitative DW MRI  evaluation in rectal cancer response assess-
ent after neoadjuvant CRT.
Our results showed that in the evaluation of ypCR the diagnos-
ic performance of the combined set of conventional and DW MR
mages was better than that of the conventional MR  image set.
ensitivity improved from 20% to 80%, NPV from 87.5% to 96.6%
nd accuracy from 87.9% to 99.6%. In 3 cases the interpretation of
dditional DW MR  images allowed us to correct diagnostic errors
ade on the basis of conventional MR  image interpretation alone,
ifferentiating viable tumor from ﬁbrosis.
Our results are consistent with those of previous studies on
ectal cancer [8,18–20] in which adding DWI  to conventional MR
equences was helpful for detecting viable tumor after neoadju-
ant CRT. In a recently published systematic review Joye et al. [6]
ound that late qualitative DWI  assessment can predict ypCR with
 pooled speciﬁcity of 94% and an overall accuracy of 87%, thereby
utperforming quantitative DWI  measurements.
The second of our purposes was to evaluate the diagnostic per-
ormance of rectal cancer’s ADC measurements for the assessment
f therapeutic response to CRT.
In our case series the overall ADC value of rectal cancer in the
re-CRT examination was signiﬁcantly lower than that in the post-
RT examination. In the ypCR and ypPR groups, the ADC value in
he pre-CRT examination was signiﬁcantly lower than that in the
ost-CRT examination, whereas in the ypSD group the difference
as not statistically signiﬁcant.
Moreover, in the pre-CRT examination the ADC value of rectal
ancer of ypCR group was signiﬁcantly lower than that of ypSD
roup (p = 0.04); though no statistically signiﬁcant difference was
ound between ADC value of rectal cancer of ypCR and ypPR groups
p = 0.2) and between ypPR and ypSD groups (p = 0.3).
In the post-CRT examination the ADC value of the ypCR group
as signiﬁcantly higher than that of ypPR and ypSD group. Simi-
arly, the  ADC post−ADC pre were signiﬁcantly different among
he three groups of tumor response, being higher in the ypCR group.
Concerning the role of rectal cancer’s ADC value in predicting
reatment outcomes our data largely conﬁrm earlier reports. Dzik-
urasz et al. found a negative correlation between the pretreatment
umor ADC value and the percentage shrinkage of the tumor after
RT in rectal cancer. DW MR  imaging was effective for the pre-
reatment prediction of treatment outcome, since patients who
esponded to treatment had a lower ADC at presentation than those
ho did not respond [21]. Likewise, the association between high
umor ADC and poor response was consistent with the known rela-
ionship between necrosis and poor response to cancer treatment.
As for ROC curve analysis we found that among the three ADC
easures (ADC pre-CRT, ADC post-CRT and  ADC post−ADC pre),
he  ADC post−ADC pre showed the best diagnostic capability in
dentifying ypCR. In particular, when an ADC > 0.3 (×10−3 mm2/s)
as used as the cut-off value for distinguishing between the ypCR
nd ypPR-ypSD groups [area under the ROC curve (AUC), 0.87], a
ensitivity of 100% and a speciﬁcity of 70.37% were obtained.
Our results are very similar to those obtained by Kim et al. [22]
hat found the percentage of the ADC increase (cut-off value of 42%)diology Open 3 (2016) 145–152 151
to be an useful predictor for ypCR with a sensitivity of 100% and a
speciﬁcity of 71%. Similarly, Lee et al. [23] reported that the percent-
age change in ADC was signiﬁcantly correlated with pathological
response.
Conversely in the study of Semedo et al. [4]  ADC post−ADC  pre
was not reliable in predicting ypCR (sensitivity of 54% and speci-
ﬁcity of 64%).
Such a discrepancy between the results of the different stud-
ies can be explained by several factors; among these the deﬁnition
of responder group (ypCR or downstaging) seems to be the most
relevant. However, the ypCR, which was used in our as in other
studies, is a more objective reference standard than tumor vol-
ume  reduction rate. The variability depending on coil systems,
scanners, magnetic ﬁeld strength and MR  imaging protocol (dif-
ferent b values), along with study population and design, different
ADC measurement methods, interobserver variability and operator
dependence on ROI positioning should also be considered.
In their systematic review, Joye et al. [6] collected the current
evidence on the role of DWI  in the prediction of ypCR before, during
and after CRT for rectal cancer. They found the following data: a
low pretreatment ADC, the change in ADC after 10–15 fractions
of radiation therapy (ADCduring) and a high ADCpost value were
signiﬁcantly correlated with ypCR.
Consistent with this previous report, our results conﬁrm the
potential of pre-CRT examination ADC value to predict treatment
response even before the start of therapy and the assumption that
the change in ADC values ( ADC post−ADC pre) has the potential
to provide a surrogate biomarker of treatment response in rectal
cancer.
Nevertheless, as demonstrated by previous Authors [6], no tech-
nique alone is accurate enough to safely select patients with ypCR;
indeed, in our study, although a speciﬁcity of 100%, qualitative DWI
analysis showed a sensitivity of 80%, and quantitative ADC  assess-
ment, despite a sensitivity of 100%, yielded a speciﬁcity of 70%.
The present study has some limitations. The ﬁrst limitation is
due to its retrospective design which may  predispose to selection
bias. Second, we used 2 b-values (0 and 800 s/mm2) for ADC cal-
culations and did not investigate the possible inﬂuence of other
b-values. Third, our study lacks an early follow-up MR examination
that could allow an earlier and accurate prediction of the patholog-
ical tumor response during CRT treatment, thus enabling to guide
modiﬁcations of the treatment protocol [24].
5. Conclusions
In our series, use of qualitative DW MR imaging assessment
in addition to conventional MR  imaging yielded better diagnostic
accuracy in the evaluation of ypCR to neoadjuvant CRT in patients
with locally advanced rectal cancer.
A low tumor ADC value in the pre-CRT examination, a high ADC
value in the post-CRT examination, a high  ADC post−ADC pre
[>0.3 (×10−3 mm2/s)] were predictive of ypCR.
Nevertheless, although DW sequences improve MR  capability
to evaluate tumor response to CRT, no functional MR  technique
alone seems accurate enough to safely select patients with ypCR.
Therefore, only a multidisciplinary approach based on the combi-
nation of morphological techniques (high-resolution T2-weighted
sequences), different functional imaging modalities (qualitative
and quantitative DWI), endoscopic ﬁndings, clinical data and lab-
oratory parameters might allow to reach a sufﬁcient diagnostic
accuracy to select patients candidable for organ-sparing strategies.
The contribution of DW MRI  in the study of rectal cancer needs
further evaluation in a larger study cohort and prospective, multi-
center trials are necessary to fully evaluate the impact of functional
1 l of Ra
M
o
C
w
e
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[24] D. Musio, F. De Felice, A.L. Magnante, M.  Ciolina, C.N. De Cecco, M.  Rengo, A.
Redler, A. Laghi, N. Raffetto, V. Tombolini, Diffusion-weighted magnetic
resonance application in response prediction before, during, and after
neoadjuvant radiochemotherapy in primary rectal cancer carcinoma, Biomed.
Res.  Int. 2013 (2013) 740195, http://dx.doi.org/10.1155/2013/740195.52 P.V. Foti et al. / European Journa
RI  on clinical decision making (surgery, conservative treatment
r “wait and watch” approach).
onﬂicts of interest
None.
All authors disclose any ﬁnancial and personal relationships
ith other people or organizations that could inappropriately inﬂu-
nce their work.
eferences
[1] A. Maier, M.  Fuchsjäger, Preoperative staging of rectal cancer, Eur. J. Radiol. 47
(2003) 89–97.
[2] U.I. Attenberger, L.R. Pilz, J.N. Morelli, D. Hausmann, F. Doyon, R. Hofheinz, P.
Kienle, S. Post, H.J. Michaely, S.O. Schoenberg, D.J. Dinter, Multi-parametric
MRI  of rectal cancer—do quantitative functional MR measurements correlate
with radiologic and pathologic tumor stages? Eur. J. Radiol. 83 (2014)
1036–1043, http://dx.doi.org/10.1016/j.ejrad.2014.03.012.
[3]  M.  Maas, P.J. Nelemans, V. Valentini, et al., Long-term outcome in patients
with a pathological complete response after chemoradiation for rectal cancer:
a  pooled analysis of individual patient data, Lancet Oncol. 11 (2010) 835–844.
[4] L.C. Semedo, D.M. Lambregts, M.  Maas, et al., Rectal cancer: assessment of
complete response to preoperative combined radiation therapy with
chemotherapy conventional MR volumetry versus diffusion-weighted MR
imaging, Radiology 260 (2011) 734–743.
[5] E. Kluza, E.D. Rozeboom, M. Maas, M.  Martens, D.M. Lambregts, J. Slenter, G.L.
Beets, R.G. Beets-Tan, T2 weighted signal intensity evolution may  predict
pathological complete response after treatment for rectal cancer, Eur. Radiol.
23  (2013) 253–261, http://dx.doi.org/10.1007/s00330-012-2578-z.
[6]  I. Joye, C.M. Deroose, V. Vandecaveye, K. Haustermans, The role of
diffusion-weighted MRI  and (18)F-FDG PET/CT in the prediction of pathologic
complete response after radiochemotherapy for rectal cancer: a systematic
review, Radiother. Oncol. 113 (2014) 158–165, http://dx.doi.org/10.1016/j.
radonc.2014.11.026.
[7] S.D. Allen, A.R. Padhani, A.S. Dzik-Jurasz, R. Glynne-Jones, Rectal carcinoma:
MRI  with histologic correlation before and after chemoradiation therapy, AJR
Am.  J. Roentgenol 188 (2007) 442–451.
[8] S.H. Kim, J.M. Lee, S.H. Hong, G.H. Kim, J.Y. Lee, J.K. Han, B.I. Choi, Locally
advanced rectal cancer: added value of diffusion-weighted MR imaging in the
evaluation of tumor response to neoadjuvant chemo- and radiation therapy,
Radiology 253 (2009) 116–125, http://dx.doi.org/10.1148/radiol.2532090027.
[9]  L. Monguzzi, D. Ippolito, D.P. Bernasconi, C. Trattenero, S. Galimberti, S. Sironi,
Locally advanced rectal cancer: value of ADC mapping in prediction of tumor
response to radiochemotherapy, Eur. J. Radiol. 82 (2013) 234–240, http://dx.
doi.org/10.1016/j.ejrad.2012.09.027.
10] D.J. Kim, J.H. Kim, J.S. Lim, J.S. Yu, J.J. Chung, M.J. Kim, K.W. Kim, Restaging of
rectal cancer with MR imaging after concurrent chemotherapy and radiation
therapy, Radiographics 30 (2010) 503–516, http://dx.doi.org/10.1148/rg.
302095046.
11] B. Barbaro, R. Vitale, L. Leccisotti, F.M. Vecchio, L. Santoro, V. Valentini, C.
Coco, F. Pacelli, A. Crucitti, R. Persiani, L. Bonomo, Restaging locally advanced
rectal cancer with MR imaging after chemoradiation therapy, Radiographics
30 (2010) 699–716, http://dx.doi.org/10.1148/rg.303095085.diology Open 3 (2016) 145–152
12] L. Curvo-Semedo, D.M. Lambregts, M.  Maas, G.L. Beets, F. Caseiro-Alves, R.G.
Beets-Tan, Diffusion-weighted MRI  in rectal cancer: apparent diffusion
coefﬁcient as a potential noninvasive marker of tumor aggressiveness, J.
Magn. Reson. Imaging 35 (2012) 1365–1371.
13] Lu Zhi-hua, Hu Chun-hong, Qian Wei-xin, Cao Wen-hong, Preoperative
diffusion-weighted imaging value of rectal cancer: preoperative T staging and
correlations with histological T stage, J. Clin. Imaging (2015), http://dx.doi.
org/10.1016/j.clinimag.2015.12.006.
14] D.M. Koh, D.J. Collins, Diffusion-weighted MRI  in the body: applications and
challenges in oncology, AJR Am.  J. Roentgenol. 188 (2007) 1622–1635.
15] E. Neri, E. Guidi, F. Pancrazi, M.  Castagna, E. Castelluccio, R. Balestri, P.
Buccianti, L. Masi, A. Falcone, B. Manfredi, L. Faggioni, C. Bartolozzi, MRI
tumor volume reduction rate vs tumor regression grade in the pre-operative
re-staging of locally advanced rectal cancer after chemo-radiotherapy, Eur. J.
Radiol. 84 (2015) 2438–2443, http://dx.doi.org/10.1016/j.ejrad.2015.08.008.
16] S.F. Carbone, L. Pirtoli, V. Ricci, D. Venezia, T. Carfagno, S. Lazzi, V.
Mourmouras, B. Lorenzi, L. Volterrani, Assessment of response to
chemoradiation therapy in rectal cancer using MR volumetry based on
diffusion-weighted data sets: a preliminary report, Radiol. Med. 117 (2012)
1112–1124, http://dx.doi.org/10.1007/s11547-012-0829-3.
17]  M.  Lambrecht, C. Deroose, S. Roels, V. Vandecaveye, F. Penninckx, X. Sagaert,
E. van Cutsem, F. de Keyzer, K. Haustermans, The use of FDG-PET/CT and
diffusion-weighted magnetic resonance imaging for response prediction
before, during and after preoperative chemoradiotherapy for rectal cancer,
Acta Oncol. 49 (2010) 956–963, http://dx.doi.org/10.3109/0284186X.2010.
498439.
18] S. Sassen, M.  de Booij, M.  Sosef, et al., Locally advanced rectal cancer: is
diffusion weighted MRI  helpful for the identiﬁcation of complete responders
(ypT0N0) after neoadjuvant chemoradiation therapy? Eur. Radiol. 23 (2013)
3440–3449.
19] D.M. Lambregts, V. Vandecaveye, B. Barbaro, et al., Diffusion-weighted MRI  for
selection of complete responders after chemoradiation for locally advanced
rectal cancer: a multicenter study, Ann. Surg. Oncol. 18 (2011) 2224–2231.
20] I. Song, S.H. Kim, S.J. Lee, J.Y. Choi, M.J. Kim, H. Rhim, Value of
diffusion-weighted imaging in the detection of viable tumour after
neoadjuvant chemoradiation therapy in patients with locally advanced rectal
cancer: comparison with T2 weighted and PET/CT imaging, Br. J. Radiol. 85
(2012) 577–586.
21] A. Dzik-Jurasz, C. Domenig, M.  George, et al., Diffusion MRI for prediction of
response of rectal cancer to chemoradiation, Lancet 360 (2002) 307–308.
22] S.H. Kim, J.Y. Lee, J.M. Lee, J.K. Han, B.I. Choi, Apparent diffusion coefﬁcient for
evaluating tumour response to neoadjuvant chemoradiation therapy for
locally advanced rectal cancer, Eur. Radiol. 21 (2011) 987–995.
23] E.M. Lee, Y.S. Hong, K.P. Kim, et al., Phase II study of preoperative
chemoradiation with S-1 plus oxaliplatin in patients with locally advanced
rectal cancer, Cancer Sci. 104 (2013) 111–115.
